Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 122
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Crowdcuring the Blues: People, Technology and Research Against Depression

    Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

    Are endangered tigers in Nepal threatened by diseases from dogs and cats?

    Through our wildlife health work in Nepal, we have seen sick tigers that show symptoms similar to canine...

    How does Sprint Training Impact Blood Sugar and Inflammation?

    Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...

    Backer Badge Funded